Companies: 10,795·Total market cap: $144.5T

Legend Biotech Corporation

Legend Biotech Corporation

LEGNNASDAQHealthcare● Active

$30.92

$-1.70(-5.20%)

Market Cap$5.7B

P/E Ratio—

52W High$45.297

52W Low$16.24

Avg Volume2.3M

Open$32.50

Beta0.35

Legend Biotech Corporation（LEGN）SEC 证券文件与年度报告

基于 SEC EDGAR 的监管申报（10-K、10-Q、8-K）、最新类型与完整申报历史；下方可跳转财务报表与盈利数据。

SEC EDGAR · data.sec.gov · CIK 0001801198 · LEGN · NASDAQ · 截至 2026年6月8日

申报快照

346

申报总数

6-K

最新类型

2026-06-02

最近提交

2020

起始年份

财务报表盈利数据在 EDGAR 查看全部

数据来源：SEC EDGAR (data.sec.gov) · CIK 0001801198 · 每小时更新 · 非投资建议

最新年度报告

20-F · 年度报告（外国发行人）财年

提交日期

2026-03-10

财年末

Mar 10, 2026

受理编号

0001801198-26-000008

主要文件

legn-20251231.htm

在 SEC EDGAR 查看下载 PDF 文件索引

数据来源：data.sec.gov · CIK 0001801198 · 受理号 0001801198-26-000008

最新关键披露

10-Q季度报告

暂无最新申报

8-K即时报告

暂无最新申报

Form 4内幕交易

持股变动披露

高管与董事交易披露。完整买卖情绪分析请查看专属 Tab。

查看内幕交易 Tab

SEC 申报历史

隐藏 Form 4 / 144

提交日期

文件类型

说明

查看

2026-06-02

6-K

Current Report (Foreign Issuer)

FORM 6-K

0001171843-26-003866

6-KCurrent Report (Foreign Issuer)

FORM 6-K

2026-06-02

2026-06-01

6-K

Current Report (Foreign Issuer)

FORM 6-K

0001171843-26-003825

6-KCurrent Report (Foreign Issuer)

FORM 6-K

2026-06-01

2026-05-21

6-K

Current Report (Foreign Issuer)

FORM 6-K

0001171843-26-003622

6-KCurrent Report (Foreign Issuer)

FORM 6-K

2026-05-21

2026-05-12

6-K

Current Report (Foreign Issuer)

6-K

0001801198-26-000014

6-KCurrent Report (Foreign Issuer)

6-K

2026-05-12

2026-04-14

6-K

Current Report (Foreign Issuer)

FORM 6-K

0001171843-26-002425

6-KCurrent Report (Foreign Issuer)

FORM 6-K

2026-04-14

2026-03-18

3

Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

0001814673-26-000003

3Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

2026-03-18

2026-03-18

3

Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

0002114170-26-000002

3Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

2026-03-18

2026-03-18

3

Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

0002088468-26-000003

3Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

2026-03-18

2026-03-18

3

Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

0002068365-26-000002

3Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

2026-03-18

2026-03-18

3

Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

0002121501-26-000002

3Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

2026-03-18

2026-03-18

3

Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

0002106809-26-000002

3Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

2026-03-18

2026-03-18

3

Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

0001974687-26-000002

3Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

2026-03-18

2026-03-18

3

Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

0001845292-26-000002

3Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

2026-03-18

2026-03-18

3

Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

0002097065-26-000002

3Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

2026-03-18

2026-03-18

3

Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

0001796536-26-000002

3Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

2026-03-18

显示 1–15，共 278 条Form 4 / 144 已隐藏· EDGAR 共 346 条

关于 SEC 申报文件与 10-K 年报

数据来源： SEC EDGAR (data.sec.gov) | 更新时间： Hourly | CIK： 0001801198 | 交易所： NASDAQ · Healthcare

Legend Biotech Corporation（NASDAQ：LEGN）自 2020 年 IPO 以来已向美国证券交易委员会（SEC）提交 346 份文件。CIK 为 0001801198，所有申报文件均可通过 SEC EDGAR 数据库免费查阅。

10-K 年度报告是 Legend Biotech Corporation 最全面的监管披露文件。最新 LEGN 10-K 于 2026-03-10 提交，财年截至 2026。历史年报可查阅 2020 至 2026 年度。

投资者可通过上方链接直接访问 Legend Biotech Corporation SEC 申报文件，包括 10-K 年报、10-Q 季报、8-K 即时披露及代理声明（DEF 14A）。

数据来源：SEC EDGAR · data.sec.gov · Form 10-K · 10-Q · 8-K2026-06-08

相关公司 SEC 申报 — Healthcare

SRRK SEC Filings →CGON SEC Filings →CELC SEC Filings →XENE SEC Filings →IDYA SEC Filings →ADPT SEC Filings →TARS SEC Filings →IRON SEC Filings →

→ LEGN 财务报表 → LEGN 盈利数据 → LEGN 内幕交易

常见问题

LEGN SEC 申报 · 8 个问题

Legend Biotech Corporation（LEGN）的 SEC 申报文件可在本页及 SEC EDGAR（sec.gov）免费查阅。CIK 为 0001801198。

LEGN SEC 申报Legend Biotech Corporation SEC 文件LEGN 10-K 查找